The FDA has warned Americans never to use drugs like ivermectin, which are “meant for animals.”
Now, a clinical trial led by MedinCells and unexpectedly funded by the Bill & Melinda Gates Foundation has confirmed the safety of ivermectin.
According to the press release, no side effects were observed with three doses of ivermectin up to 100 mcg / kg given continuously for 1 month in healthy volunteers.
The study began in September 2020 and ended in March 2021.
Following the completion of the study, Professor Jacques Descotes, Professor Emeritus at the University of Lyon Claude Bernard, conducted a peer review.
His conclusion: Hundreds of millions of people have been treated with ivermectin for curative or prophylactic purposes around the world over the past 3 decades. The author of this analysis of the available medical data concludes that the safety profile of ivermectin has so far been excellent in the majority of treated patients, so that the toxicity of ivermectin to humans cannot be considered a major cause for concern.
On April 6, 2020, Medincell announced the launch of its COVID-19 program. This program aims to develop a long-acting injectable form of ivermectin to protect people who are not infected with COVID-19 in order to break the chain of transmission of the virus.
Medincell SA is a French biological products and pharmaceuticals manufacturer that works on both commercial and non-commercial projects.
MedinCell received a grant from the Bill & Melinda Gates Foundation in 2019 and signed an agreement to provide an additional $ 19 million over four years.
In August 2021, the French company received another grant from the Bill & Melinda Gates Foundation. This goal is to support the evaluation of the long-acting injectable ivermectin as an endectocide for malaria control.
Follow us in: Telegram